TCM
CNTA

Tang Capital Management’s Centessa Pharmaceuticals CNTA Stock Holding History

Tang Capital Management’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-200,000
Closed -$4.85M – 104
2025
Q3 		$4.85M Buy
200,000
+150,000
+300% +$2.67M 0.19% 95
2025
Q2 		$657K Hold
50,000
– – 0.03% 179
2025
Q1 		$719K Buy
+50,000
New +$818K 0.04% 174
2024
Q4 		– Sell
-400,000
Closed -$6.4M – 185
2024
Q3 		$6.4M Buy
+400,000
New +$4.9M 0.46% 62

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Tang Capital Management's CNTA Position: Q4 2025 in Review

Tang Capital Management sold out of Centessa Pharmaceuticals (CNTA) in Q4 2025, closing a stake of 200,000 shares — an estimated $4.85M sold.

Tang Capital Management first reported a position in CNTA in Q3 2024 and held it in 4 quarters. The position peaked at $6.4M in Q3 2024. 146 funds tracked by Wall St. Rank hold CNTA as of Q4 2025.

  • Tang Capital Management reported no remaining Centessa Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Tang Capital Management sold 200,000 Centessa Pharmaceuticals shares in Q4 2025, an estimated $4.85M.
  • Tang Capital Management first reported a position in Centessa Pharmaceuticals in Q3 2024 and held it in 4 quarters.
  • Tang Capital Management's Centessa Pharmaceuticals position peaked at $6.4M in Q3 2024.
  • 146 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q4 2025.

Based on Tang Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.